Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

NYSE:DNA 11:22:24 AM EDT

5.30

+0.26 (+5.16%)

Market Cap (Intraday)	10.37B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$55.25 Million
Adjusted EPS	-$0.04

See more estimates

10-Day MA	$6.16
50-Day MA	$10.01
200-Day MA	N/A

See more pivots

Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A Stock, NYSE:DNA

27 Drydock Avenue, 8th floor, Boston, Massachusetts 02210

United States of America

Phone: +1.877.422.5362

Number of Employees:

http://www.ginkgobioworks.com

Description

Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.